Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling
暂无分享,去创建一个
Tero Aittokallio | Petteri Hintsanen | Otto Kauko | Garry Corthals | Jukka Westermarck | Mikael Jumppanen | Teemu Daniel Laajala | Veronika Suni | Susumu Y. Imanishi | T. Laajala | T. Aittokallio | P. Hintsanen | J. Westermarck | G. Corthals | Veronika Suni | O. Kauko | M. Jumppanen | P. Haapaniemi | Pekka Haapaniemi
[1] Jukka Westermarck,et al. ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays , 2014, PloS one.
[2] Ruedi Aebersold,et al. Confident site localization using a simulated phosphopeptide spectral library. , 2015, Journal of proteome research.
[3] M. Copland,et al. Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression. , 2011, Blood.
[4] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[5] S. Tuomela,et al. Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation , 2012, Oncogene.
[6] S. Gabriel,et al. Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.
[7] T. Köcher,et al. Universal and confident phosphorylation site localization using phosphoRS. , 2011, Journal of proteome research.
[8] S. Joel,et al. Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells , 2013, Science Signaling.
[9] R. Bernards,et al. Protein phosphatase 2A regulatory subunits and cancer. , 2009, Biochimica et biophysica acta.
[10] W. Hahn,et al. Multiple pathways regulated by the tumor suppressor PP2A in transformation. , 2008, Trends in molecular medicine.
[11] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[12] J. Eriksson,et al. In Vivo Identification of Sumoylation Sites by a Signature Tag and Cysteine-targeted Affinity Purification* , 2010, The Journal of Biological Chemistry.
[13] I. Prior,et al. Ras isoform abundance and signalling in human cancer cell lines , 2008, Oncogene.
[14] S. Schreiber,et al. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Liu,et al. CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells , 2008, Clinical Cancer Research.
[16] J. Chen,et al. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. , 1992, Science.
[17] D. Haussler,et al. Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser , 2013, Scientific Reports.
[18] M. Mumby. PP2A: Unveiling a Reluctant Tumor Suppressor , 2007, Cell.
[19] O. Kallioniemi,et al. CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes , 2012, Oncogene.
[20] A. Takai,et al. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. , 1988, The Biochemical journal.
[21] W. Hahn,et al. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. , 2003, Cancer cell.
[22] P. Roepstorff,et al. Highly Selective Enrichment of Phosphorylated Peptides from Peptide Mixtures Using Titanium Dioxide Microcolumns* , 2005, Molecular & Cellular Proteomics.
[23] K. Kalland,et al. KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer , 2012, British Journal of Cancer.
[24] W. Hahn,et al. Identification of PP2A complexes and pathways involved in cell transformation. , 2010, Cancer research.
[25] D. Spandidos,et al. Mutations and Expression of the ras Family Genes in Leukemias , 1996, Stem cells.
[26] Yu Xue,et al. GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy *S , 2008, Molecular & Cellular Proteomics.
[27] E. Petricoin,et al. Discovery of Mouse Spleen Signaling Responses to Anthrax using Label-Free Quantitative Phosphoproteomics via Mass Spectrometry* , 2010, Molecular & Cellular Proteomics.
[28] Y Taya,et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.
[29] R. Bast,et al. Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model , 2005, Oncogene.
[30] Wen-Lian Hsu,et al. An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion. , 2010, Journal of proteome research.
[31] Bin Zhang,et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse , 2011, Nucleic Acids Res..
[32] L. Jensen,et al. KinomeXplorer: an integrated platform for kinome biology studies , 2014, Nature Methods.
[33] N. Gray,et al. Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.
[34] W. Hahn,et al. PP2A-mediated regulation of Ras signaling in G2 is essential for stable quiescence and normal G1 length. , 2014, Molecular cell.
[35] O. Jensen. Interpreting the protein language using proteomics , 2006, Nature Reviews Molecular Cell Biology.
[36] Y. Bahk,et al. A Proteomic approach for protein‐profiling the oncogenic ras induced transformation (H‐, K‐, and N‐Ras) in NIH/3T3 mouse embryonic fibroblasts , 2008, Proteomics.
[37] J. Blenis,et al. RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation* , 2007, Journal of Biological Chemistry.
[38] M. Larsen,et al. Technologies and challenges in large‐scale phosphoproteomics , 2013, Proteomics.
[39] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[40] F. Gnad,et al. Systems-wide Analysis of K-Ras, Cdc42, and PAK4 Signaling by Quantitative Phosphoproteomics* , 2013, Molecular & Cellular Proteomics.
[41] M. Mann,et al. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. , 2014, Cell reports.
[42] Garry L Corthals,et al. Reference-facilitated Phosphoproteomics , 2007, Molecular & Cellular Proteomics.
[43] U. Rapp,et al. Ras oncogenes and their downstream targets. , 2007, Biochimica et biophysica acta.
[44] Robert A. Weinberg,et al. Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation , 2002, Molecular and Cellular Biology.
[45] Carla Mattos,et al. A comprehensive survey of Ras mutations in cancer. , 2012, Cancer research.
[46] A. Cheng,et al. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells , 2010, Oncogene.
[47] Gregory Stephanopoulos,et al. Molecular Systems Biology Peer Review Process File Oncogenic K-ras Decouples Glucose and Glutamine Metabolism to Support Cancer Cell Growth Transaction Report , 2022 .
[48] T. Hunter,et al. Protein kinase signaling networks in cancer. , 2011, Current opinion in genetics & development.
[49] B. Hemmings,et al. Role of protein phosphatase 2A in the regulation of mitogen-activated protein kinase activity in ventricular cardiomyocytes. , 1996, Biochemical and biophysical research communications.
[50] R. Sears,et al. CIP2A Inhibits PP2A in Human Malignancies , 2007, Cell.
[51] W. Hahn,et al. SV40 small T antigen and PP2A phosphatase in cell transformation , 2008, Cancer and Metastasis Reviews.
[52] R. Weinberg,et al. Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.
[53] P. Cutillas,et al. Characterization of a TiO2 enrichment method for label-free quantitative phosphoproteomics , 2011, Methods.
[54] F. Haluska,et al. Genetic Alterations in Signaling Pathways in Melanoma , 2006, Clinical Cancer Research.
[55] C. Haglund,et al. Prognostic role of CIP2A expression in serous ovarian cancer , 2011, British Journal of Cancer.
[56] Robert Walgate,et al. Proliferation , 1985, Nature.
[57] M. Mumby,et al. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation , 1993, Cell.
[58] T. Roberts,et al. Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner , 2007, Proceedings of the National Academy of Sciences.
[59] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[60] R. Honkanen,et al. Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse. , 2007, Methods in molecular biology.
[61] M. Caron,et al. Quantitative Label-Free Phosphoproteomics Strategy for Multifaceted Experimental Designs , 2011, Analytical chemistry.
[62] G. Evan,et al. Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1. , 2013, Cancer discovery.
[63] Ting Wang,et al. The UCSC Cancer Genomics Browser , 2009, Nature Methods.
[64] T. Aittokallio,et al. Phosphoproteomics Combined with Quantitative 14-3-3-affinity Capture Identifies SIRT1 and RAI as Novel Regulators of Cytosolic Double-stranded RNA Recognition Pathway* , 2014, Molecular & Cellular Proteomics.
[65] S. Elledge,et al. A quantitative atlas of mitotic phosphorylation , 2008, Proceedings of the National Academy of Sciences.
[66] A. Heck,et al. Single-step Enrichment by Ti4+-IMAC and Label-free Quantitation Enables In-depth Monitoring of Phosphorylation Dynamics with High Reproducibility and Temporal Resolution * , 2014, Molecular & Cellular Proteomics.
[67] T. Hunter,et al. Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.
[68] B. Bai,et al. Proteomics analysis reveals insight into the mechanism of H-Ras-mediated transformation. , 2006, Journal of proteome research.
[69] W. Hsu,et al. Phosphoproteomics Identifies Oncogenic Ras Signaling Targets and Their Involvement in Lung Adenocarcinomas , 2011, PloS one.
[70] F. Porteu,et al. B56‐containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX‐1 and ERK , 2006, The EMBO journal.
[71] Andrew R. Jones,et al. ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.
[72] K. Lage,et al. Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues , 2012, Nature Communications.
[73] J. Yates,et al. Protein analysis by shotgun/bottom-up proteomics. , 2013, Chemical reviews.
[74] M. Mann,et al. Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.
[75] Ronald J. Moore,et al. Applying a targeted label-free approach using LC-MS AMT tags to evaluate changes in protein phosphorylation following phosphatase inhibition. , 2007, Journal of proteome research.
[76] B. Winblad,et al. Interactions between glycogen synthase kinase 3beta, protein kinase B, and protein phosphatase 2A in tau phosphorylation in mouse N2a neuroblastoma cells. , 2009, Journal of Alzheimer's disease : JAD.